SCHEMBL6936370

SCHEMBL6936370

OC[C@@H](O)CCn1ccc2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 4/20 0.61
CCND1 P24385 4/20 0.61
LMNA P02545 3/20 0.51
KMT2A Q03164 4/20 0.51
MEN1 O00255 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 2/20 0.51
MAPT P10636 2/20 0.51
TSHR P16473 1/20 0.51
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
MAPK1 P28482 3/20 0.48
AGER Q15109 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
USP2 O75604 1/20 0.47
HTT P42858 1/20 0.47
BACE1 P56817 1/20 0.46
KDM4E B2RXH2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6936381 1.00 CDK4 (0.61) CDK4CCND1LMNAKMT2AMEN1
SCHEMBL7149272 0.83 KMT2A (0.66) CDK4CCND1LMNAKMT2AMEN1
SCHEMBL30063707 0.78 CDK4 (0.76) CDK4CCND1LMNAKMT2AMEN1
SCHEMBL734246 0.78 CDK4 (0.76) CDK4CCND1LMNAKMT2AMEN1
SCHEMBL11366447 0.78 CDK4 (1.00) CDK4CCND1LMNAKMT2AALDH1A1
SCHEMBL10412119 0.77 CDK4 (0.68) CDK4CCND1LMNAKMT2AHTR2A
SCHEMBL29928685 0.77 CDK4 (0.68) CDK4CCND1LMNAKMT2AHTR2A
SCHEMBL16603958 0.77 AGER (0.71) CDK4CCND1LMNAKMT2AMEN1
SCHEMBL27518021 0.77 CDK4 (0.73) CDK4CCND1LMNAKMT2AMEN1
SCHEMBL6689749 0.77 MEN1 (0.67) CDK4CCND1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596738-B1 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 US disclosed
EP-1161429-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-12-12 EP disclosed
WO-2000055155-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-09-21 WO disclosed